How doctors can detect tuberculosis in children more quickly

Unveiling Swift TB Detection in Children

Persistent cough, tinged sputum, and breathing discomfort ...

Tuberculosis, colloquially recognized as TB, is a highly contagious, age-old illness caused by the bacterium "Mycobacterium tuberculosis." Despite its historical prevalence, this disease still ranks among the leading causes of mortality worldwide.

Every year, roughly 240,000 minor children succumb to TB, making it one of the top ten killers for kids under the age of five. The reason for this alarming statistic is simple - TB often goes undetected and untreated in children. However, this unfortunate trend may finally be reversed!

A Minimal and Swift Blood Test

An international team of researchers from Ludwig-Maximilians-Universität in Munich, spearheaded by physicians Laura Olbrich and Norbert Heinrich from the Tropical Institute, has recently tested an innovative diagnostic tool. Their South African, Malawian, Tanzanian, Mozambican, and Indian partners assisted in trials of the new analysis tool. The researchers report their findings in the prestigious journal "The Lancet Infectious Diseases."

Previous methods for TB diagnosis relied on scrutinizing the activity of microbes in sputum, a product of the deep respiratory tract. However, obtaining a sputum sample from children can be challenging. Furthermore, the number of bacteria in children is usually low, and symptoms are often unspecific, the researchers claim.

Tapping Three Genes' Activity

The new tool entails analyzing the activity of three genes within capillary blood extracted from a child's fingertip. Doctor Olbrich comments, "Within an hour, you have a result compared to most other tests that require sending samples to other laboratories."

The team tested the tool on 975 children suspected of having TB. They compared the results to traditional methods to assess the accuracy of the test.

Promising Outcomes

Dr. Olbrich expressed satisfaction at the findings. "The test identified around 60% of children with TB compared to the traditional method, with a 90% specificity. This puts the new test on par with or even superior to other diagnostic options," she concluded.

1. A potential game-changer in detecting tuberculosis (TB) in children is the investigation of an innovative diagnosis tool studied by an international team of researchers.
2. Diagnosing tuberculosis in children can present challenges, such as difficulties obtaining sputum samples and low bacteria counts, coupled with unspecific symptoms.
3. The new tool functions by analyzing genetic activity in a simplified blood sample derived from the child's fingertip, providing results outside the scope of standard tests requiring external laboratory reviews and generating results within 60 minutes.
4. The research yielded positive results, with the new test accurately detecting around 60% of children with TB, offering comparable or superior specificity percentages when compared to existing diagnostic procedures.

Source:

Enrichment Data:

The new rapid blood test, specifically the LIOFeron®TB/LTBI assay, has demonstrated significance in detecting both tuberculosis (TB) and latent TB infection (LTBI) in children. Here are some crucial highlights:

1. Performance Evaluation:
2. The LIOFeron®TB/LTBI assay demonstrated high accuracy in diagnosing Mycobacterium tuberculosis (MTB) infection, boasting an Area Under the Curve (AUC) of 0.997 in Receiver Operating Characteristic (ROC) analysis.
3. LIOFeron®TB/LTBI assay displayed 100% sensitivity in detecting LTBI, which significantly surpassed the 85.7% sensitivity of the QuantiFERON®-TB Gold Plus assay for LTBI diagnosis.
4. Comparison to Other Methods:
5. Interferon Gamma Release Assays (IGRAs): LIOFeron®TB/LTBI assay is an Interferon Gamma Release Assay (IGRA) type, preferred for detecting latent TB infections, particularly in children who have received the BCG vaccine or are less likely to return for skin test readings.
6. TB Skin Test (Mantoux Tuberculin Skin Test): While the skin test is an alternative, it has limitations, such as the need for multiple visits and the potential for false-negative results in individuals vaccinated with BCG.
7. Nucleic Acid Amplification Tests (NAATs): NAATs, like the Xpert MTB/RIF assay, are valuable tools for rapid detection of TB bacteria and identifying drug resistance. However, they do not replace the need for smear, culture, and other diagnostic methods.
8. Pediatric Considerations:
9. The LIOFeron®TB/LTBI assay stands out as a promising diagnostic solution for pediatric TB detection due to its quick turnaround time (approximately 90 minutes) and the convenience of obtaining easily obtainable fingerstick blood samples.

In summary, the LIOFeron®TB/LTBI assay is highly effective in detecting both TB and LTBI in children, offering a 100% sensitivity level for LTBI detection and high overall accuracy. The assay outperforms other diagnostic methods, especially IGRAs, and is well-suited for addressing pediatric TB challenges due to its rapid and non-invasive nature.